Total androgen-receptor gene expression inhibitor therapy (TARGET): A phase II trial of neoadjuvant SAHA (S) followed prostatectomy for patients (pts) with high-risk prostate cancer (pc) Meeting Abstract


Authors: Slovin, S. F.; Fine, S.; Nelson, P.; Steinbrecher, J.; Eastham, J.; Coleman, J.; Touijer, K. A.; Carver, B. S.; Laudone, V.; Scher, H. I.
Abstract Title: Total androgen-receptor gene expression inhibitor therapy (TARGET): A phase II trial of neoadjuvant SAHA (S) followed prostatectomy for patients (pts) with high-risk prostate cancer (pc)
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Language: English
ACCESSION: WOS:000208852001138
DOI: 10.1200/jco.2010.28.15_suppl.e15133
PROVIDER: wos
Notes: Meeting Abstract: e15133 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Coleman
    341 Coleman
  2. Vincent Laudone
    136 Laudone
  3. Susan Slovin
    254 Slovin
  4. Karim Abdelkrim Touijer
    257 Touijer
  5. James Eastham
    537 Eastham
  6. Brett Stewart Carver
    143 Carver
  7. Samson W Fine
    462 Fine
  8. Howard Scher
    1130 Scher